LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
China Aluminum International Engineering Corporation (02068) released its performance for the first three quarters, with a net profit attributable to the parent company of 119 million yuan, a year-on-year decrease of 52.68%.
BQD(03866) issued 2 billion yuan non-fixed-term capital bonds.
BQD (03866) registered a net profit attributable to shareholders of 3.992 billion yuan in the first three quarters, an increase of 15.54% year-on-year.
China Aluminum International Engineering Corporation (02068) released its performance for the first three quarters, with a net profit attributable to the parent company of 119 million yuan, a year-on-year decrease of 52.68%.
BQD(03866) issued 2 billion yuan non-fixed-term capital bonds.
BQD (03866) registered a net profit attributable to shareholders of 3.992 billion yuan in the first three quarters, an increase of 15.54% year-on-year.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
